Agilent Technologies, Inc. (NYSE:A) Shares Bought by Allworth Financial LP

Allworth Financial LP grew its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 55.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,647 shares of the medical research company's stock after purchasing an additional 2,361 shares during the quarter. Allworth Financial LP's holdings in Agilent Technologies were worth $893,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. McAdam LLC grew its position in shares of Agilent Technologies by 3.1% in the third quarter. McAdam LLC now owns 2,531 shares of the medical research company's stock valued at $376,000 after purchasing an additional 77 shares during the last quarter. Brown Brothers Harriman & Co. grew its position in shares of Agilent Technologies by 13.5% in the third quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company's stock valued at $96,000 after purchasing an additional 77 shares during the last quarter. Rovin Capital UT ADV boosted its position in Agilent Technologies by 1.6% during the third quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company's stock worth $750,000 after acquiring an additional 81 shares during the last quarter. Integrated Advisors Network LLC boosted its position in Agilent Technologies by 2.5% during the third quarter. Integrated Advisors Network LLC now owns 3,582 shares of the medical research company's stock worth $532,000 after acquiring an additional 86 shares during the last quarter. Finally, Ascent Group LLC boosted its position in Agilent Technologies by 4.1% during the third quarter. Ascent Group LLC now owns 2,209 shares of the medical research company's stock worth $328,000 after acquiring an additional 87 shares during the last quarter. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A has been the topic of a number of analyst reports. Citigroup raised their target price on shares of Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research report on Thursday, December 19th. Bank of America decreased their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a research report on Friday, December 13th. StockNews.com upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Tuesday, December 24th. JPMorgan Chase & Co. decreased their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a research report on Tuesday, November 26th. Finally, Barclays upgraded shares of Agilent Technologies from an "underweight" rating to an "equal weight" rating and raised their target price for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Agilent Technologies currently has a consensus rating of "Moderate Buy" and a consensus target price of $144.38.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm's stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company's stock, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.26% of the company's stock.

Agilent Technologies Trading Down 0.8 %

NYSE:A traded down $1.12 during trading hours on Friday, reaching $135.67. 476,161 shares of the company were exchanged, compared to its average volume of 1,620,432. The stock has a 50 day simple moving average of $141.04 and a 200 day simple moving average of $139.28. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The firm has a market cap of $38.71 billion, a price-to-earnings ratio of 30.69, a PEG ratio of 3.71 and a beta of 1.07.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, beating analysts' consensus estimates of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the firm posted $1.38 EPS. The business's revenue for the quarter was up .8% compared to the same quarter last year. As a group, analysts predict that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies's dividend payout ratio is presently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.